Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: Experience at a single institution

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 858-862

  Teng, Da Hong ^a   Zhu, Zhi Jun ^a   Zheng, Hong ^a   Deng, Yong Lin ^a   Sun, Li Ying ^a   Pan, Cheng ^a   Liu, Yi He ^a   Song, Hong Li ^a   Shen, Zhong Yang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Recurrence; Steatosis donor

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FATTY LIVER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CHINA; DONOR SELECTION; FATTY LIVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860525716     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12007     Document Type: Article

References (24)

1. Mazzaferro V, Chun YS, Poon RT: Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008; 15:1001-1007.
2. Mazzaferro V, Regalia E, Doci R: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
3. Yao FY, Ferrell L, Bass NM: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394-1403. (Pubitemid 32496976)
4. Toso C, Trotter J, Wei A: Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008; 14:1107-1115.
5. Mazzaferro V, Llovet JM, Miceli R: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10:35-43.
6. Fisher RA, Kulik LM, Freise CE: Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7:1601-1608. (Pubitemid 46776250)
7. Lo CM, Fan ST, Liu CL, Chan SC: Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94:78-86. (Pubitemid 46142736)
8. Van der Bilt JD, Kranenburg O, Nijkamp MW: Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005; 42:165-175. (Pubitemid 40911324)
9. Man K, Ng KT, Lo CM: Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl 2007; 13:1669-1677.
10. Nicoud IB, Jones CM, Pierce JM: Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Res 2007; 67:2720-2728. (Pubitemid 46548960)
11. Shi JH, Huitfeldt HS, Suo ZH: Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl 2011; 17:866-874.
12. Anderson CD, Upadhya G, Conzen KD: Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl 2011; 17:189-200.
13. Hasegawa T, Ito Y, Wijeweera J: Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1385-1395. (Pubitemid 47084668)
14. Tania Roskams, Shi Qi Yang, Aymen Koteish: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163:1301-1311.
15. Doyle MB, Vachharajani N, Wellen JR: Short- and long-term outcomes after steatotic liver transplantation. Arch Surg 2010; 145:653-660.
16. Avolio AW, Frongillo F, Nicolotti N: Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27. Transplant Proc 2009; 41:208-212.
17. Vitale A, D'Amico F, Brolese A: Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. Transplant Proc 2007; 39:1907-1909. (Pubitemid 47208574)
18. McCormack L, Petrowsky H, Jochum W: Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246:940-946. (Pubitemid 350179176)
19. Adinolfi LE, Gambardella M, Andreana A: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33:1358-1364. (Pubitemid 32496971)
20. Busuttil RW, Tanaka K: The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9:651-663. (Pubitemid 36874450)
21. Nanashima A, Pillay P, Verran DJ: Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc 2002; 34:1231-1235. (Pubitemid 34665326)
22. Brokelman W, Stel AL, Ploeg RJ: Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin Solution era. Transplant Proc 1999; 31:2087-2090. (Pubitemid 29376534)
23. Shen ZY, Zhu ZJ, Zheng WP: Prognostic factors influencing the outcomes of liver transplantation in patients of primary liver carcinoma. Chin J Gen Surg 2007; 22:241-245 (In Chinese with English abstract).
24. Van der Bilt JD, Kranenburg O, Borren A: Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol 2008; 15:1392-1398.